SynthesisJournal of epidemiology and global health2026
Seroprevalence and Molecular Epidemiology of Hepatitis B and D Viruses in Mauritania: a Systematic Review and Meta-Analysis.
Synthesis in Journal of epidemiology and global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mauritania has a high prevalence of chronic hepatitis B virus (HBV) and hepatitis D virus (HDV), posing a major public health burden. A comprehensive analysis of seroprevalence, transmission dynamics, and molecular epidemiology would help inform strategies for public health interventions. This study systematically reviews the published literature in the field between 1983 and 2024, employing PRISMA 2020 guidelines. Where insufficient data were available for meta-analyses on specific inquiries, summative descriptions were included. Eight studies involving 19,781 participants were included. The pooled HBsAg seroprevalence was 15.2% (95% CI: 12.8%–18.0%; I2 = 91.9%; p < 0.0001) by meta-analysis. Among HBV-exposed individuals, male sex, lower education levels, and certain occupations were more commonly observed. Genotype D dominated HBV strains (50%), followed by E (36.2%), A (12%), and G (0.5%). Among 1739 HBsAg-positive individuals from five studies, the seroprevalence of anti-HDV antibodies was 21.2% (95% CI, 14.7%—29.4%; I2 = 94.1%; p < 0.0001), with HDV-RNA detectable in 52.0% of cases. Occupation and geographic location were more commonly observed among HDV-infected individuals. HDV-1 was the predominant genotype (89.3%), followed by HDV-5 (10.7%). Given the dual epidemic of HBV and HDV faced by Mauritania, targeted public health strategies will be needed. This systematic review and meta-analysis outlines some of the known epidemiology, both molecular and social, to aid the focus of public health programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.